EnhancerAtlas 2.0: an updated resource with typical enhancer annotation in 600 tissue/cell types across nine species
EnhancerAtlas 2.0
TagContent
EnhancerAtlas ID
HS082-14392 
Organism
Homo sapiens 
Tissue/cell
HCASMC 
Coordinate
chr17:15795600-15798680 
TF binding sites/motifs
Number: 25             
TFJASPAR IDCoordinateMotif SequenceStrand-Log10(p-value)
EWSR1-FLI1MA0149.1chr17:15796782-15796800CCTTCCTTCCTTCCTTCC-10.83
EWSR1-FLI1MA0149.1chr17:15796786-15796804CCTTCCTTCCTTCCTTCC-10.83
EWSR1-FLI1MA0149.1chr17:15796802-15796820CCCTCCCTCCCTCCCTCC-6.03
EWSR1-FLI1MA0149.1chr17:15796806-15796824CCCTCCCTCCCTCCCTCC-6.03
EWSR1-FLI1MA0149.1chr17:15796810-15796828CCCTCCCTCCCTCCTCCC-6.03
EWSR1-FLI1MA0149.1chr17:15796814-15796832CCCTCCCTCCTCCCTTTC-6.05
EWSR1-FLI1MA0149.1chr17:15796822-15796840CCTCCCTTTCTTCCTCCC-6.6
EWSR1-FLI1MA0149.1chr17:15796778-15796796CAGCCCTTCCTTCCTTCC-6.83
EWSR1-FLI1MA0149.1chr17:15796798-15796816CCTTCCCTCCCTCCCTCC-6.94
EWSR1-FLI1MA0149.1chr17:15796818-15796836CCCTCCTCCCTTTCTTCC-7.47
EWSR1-FLI1MA0149.1chr17:15796794-15796812CCTTCCTTCCCTCCCTCC-8.45
EWSR1-FLI1MA0149.1chr17:15796790-15796808CCTTCCTTCCTTCCCTCC-9.47
GRHL1MA0647.1chr17:15796503-15796515CTAACCGGTTTT-6.11
IRF1MA0050.2chr17:15795958-15795979TCTTTCTTTCTTTTTTTTTTT+6.25
ZNF263MA0528.1chr17:15798002-15798023GGAGGAGGAGAGGAAGAAGTC+6.06
ZNF263MA0528.1chr17:15796786-15796807CCTTCCTTCCTTCCTTCCCTC-6.24
ZNF263MA0528.1chr17:15796809-15796830TCCCTCCCTCCCTCCTCCCTT-6.67
ZNF263MA0528.1chr17:15797999-15798020AGGGGAGGAGGAGAGGAAGAA+6.8
ZNF263MA0528.1chr17:15796782-15796803CCTTCCTTCCTTCCTTCCTTC-6.94
ZNF263MA0528.1chr17:15796790-15796811CCTTCCTTCCTTCCCTCCCTC-7.27
ZNF263MA0528.1chr17:15796798-15796819CCTTCCCTCCCTCCCTCCCTC-7.63
ZNF263MA0528.1chr17:15796794-15796815CCTTCCTTCCCTCCCTCCCTC-7.95
ZNF263MA0528.1chr17:15796802-15796823CCCTCCCTCCCTCCCTCCCTC-7.97
ZNF263MA0528.1chr17:15796818-15796839CCCTCCTCCCTTTCTTCCTCC-8.54
ZNF263MA0528.1chr17:15796806-15796827CCCTCCCTCCCTCCCTCCTCC-9.64
Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder
Number of disease enhancers: 2             
ChromosomeStartEnd
chr171579671515797290
chr171579577715795868
Number: 3             
IDChromosomeStartEnd
GH17I015892chr171579550415797023
GH17I015893chr171579708115797230
GH17I015894chr171579771515797914
Enhancer Sequence
GCCTTCTGAG TAGCTGGATT ACAGACAGGC ACCACCACGC CTGACTAATT TTTGTATTTT 60
TAATAGAGAC AGGGTTTTTG CCCTGTTGAC CAGGCTGGTC TCAGATTCCA GACCTCAGGT 120
GATCCACCCG CCTTGGCCTT CCAAAGTGCT GGGATTACAG GTGTTAGCCA CCGTGCTCGG 180
CCGAATTTTT TCATCATGTT GGCCAGGCTG GTCTTGAACG TCTGACCTCA AGTGATCCGA 240
CTGACTCGGT CCCCCAAACT GCTGGGATTA TAGGCATGAG CCATGACGCC TGGCCCATAC 300
AGCATTTTCT AATTAGTGTC CTGCCTCTTT CCCAAGAAGC TTTGCTTTTT TCTTTTTTTC 360
TTTCTTTCTT TTTTTTTTTT TTGACTTTAG CAGTTAGTGT ACACAGAGTC AATTCATTAA 420
TAGACACCTC ATGGAGGCAC CTAGAGGACC TCGGCAAAGG TGAAGAAGTA CTGGGAATGC 480
AGCCATGAAT CCAACTGTGT CCTCAGTGGA ATTTAGCACA GTACACAATT CAGTGTGTAC 540
CCTGCAGCTT CTCCCCGACA GTGATTGATG TCTTTATGAA ATGTTAGTAA CCAAGGCAAG 600
GCAAGTAACC AGGCAATCAA GGCAAGCGAA AGCATCTTCT AGAAGCAAAT GTCGTGGGCT 660
GTGCGGTTTT GCTTTACCCC GTCCTGCTGC ATTATTCATG AGTACTGTCT CTACATTCCC 720
CCGTCTGGAA CTTTAATACA ACCTCAACAC TCTGGGAAGA TATTCTTGTA TATGCACTAA 780
AATTAGGATT TTACCTTCCC ATGTGCAATT CAATATCTTC ATTTTTCTCA AATGACTTTT 840
GCTGCATTGA GGGAAATAAA ATTCTGTGTA TTACACAATA TTTGTTTAAG CTCTCCTAGA 900
GACCTAACCG GTTTTGGAGA TGCTTGGAAT GTTAACCTTT TTTATATCTG AGACTTCCTT 960
CTATCAAAAA GTCCCATATC CTACTGAGAA ATATCTCTAA GGTATTTATA TCCTAGGGAA 1020
AGTTAGAGAT AATTTGCAAT GAGTAACTAC CATTTCCCTG GGGAAAAATA ATGTTAAGTT 1080
TCTTTCTGTT TTTGCTTTTT CCTCCCAATA AATCTTGTAC ATAAATTCTA AATGTTATCA 1140
TTCAGAGTGG ACACCACACT CCAGACCCTT AAGATAATCA GCCCTTCCTT CCTTCCTTCC 1200
TTCCCTCCCT CCCTCCCTCC CTCCTCCCTT TCTTCCTCCC TGCTGTAGCT ACTGATAAGT 1260
TCCTTTCACT GCTTTCCAGA GAAAGCCCTG CTGGAATCTC ACCTTCGTGT TTCAAGACCT 1320
TGGCCAGCAT TTTTCAAAGC CTATTCCAAA GAACCAGCAA GCACCAACAA AACATTCCCT 1380
GCTGGAGCAC TGTATATTAC ATGACATTTG TAGACAGCAC AGTGTCTATT AACACATTAA 1440
AGACTTCAAG AAGTCCTACA TTAAGAAATC TGTGTGACTG TTTAACCCAA CATAGCGCAG 1500
ATCCACATAA CCTCTTTACT TAGGTTTGTT TATTTTACTA CAATCACCAT AACAAGTGTT 1560
GGCAGATTTT CCCTGTTAAG GGCCACGTAA TAGGATCAGG GGTCAGTTGG TCTCAGTCAC 1620
AACTATTCAA CTCTACCATT GGGCTAAAGA GGCCTTCAAC ACTTTGTAAA TGAATGGGCA 1680
TGGCTGTGTC CCAACAAAAG TTTATTATAT GAAAACAGGC TATAAGCCAG ATTTGGCCCA 1740
TGGGCAGCAG TTTGTCAACC CCTGACCTAG AACATCCTAC AATATGTCCC ACAGAACATA 1800
CTTTGGAAAA TGCTGTGCTG GGCCCTACAC TCGGTCACTC AAGAATTTCT TGCCAAGGAC 1860
TGGGCACCAT AATAAGACAG CAGTCAACAA GAGACATGTT CTCTGAACTC ATGAACTCTG 1920
AACTGTCATG CCCTCCTGAA CTACACAGAC AAGCAAGCGG TAGACTTTAT AACAAGTAAA 1980
GTTATTAATG AACAAGGATA AGTCGTCAAA GAGCCCAGAG AGAAACTCAG TGCTGTGAGA 2040
GTCAGTGACA GGGATCACAT TTAGATGAGG GGAGACAGTG GCAGTGATGT CAAAATCGGT 2100
GTCAGAAGGT GGAGGAGGCA GCAGTGCAGA GCCAGGGCGA AGGAGTAGCT GCAGCCAGGA 2160
AACACCTTGG TGTGGTCAAG GACATGGAAG AAAGCTGGTT GGCTGGATGC AGTTAGTGGG 2220
GCCAGGGAGG CTGTGCTGAT CCAGGGAGTC CAAGGGGGCA GGGCCTGCAG AGCTTCCATG 2280
GCTCAGGTTT GGCCTCACCC AGTAACCACG AGAGTGGTAG CAACGCAGAT GGAAAGACAT 2340
AGAAAGATTA GAAATATGTC TTAGACAGAA TCAGCTGGAC TTAGTGACAG ATTGGTTGTA 2400
GGGGAGGAGG AGAGGAAGAA GTCAAACACA ACACCATGGT GTCTGGTTGG ACAGGGCCAT 2460
TTTCTGAGAT GGGGAGGGCA TAGATATGTT TAAAAGCTCT GTTTTGATTA CTCCACATCA 2520
GGATTTAAAT AAAGTCCAAA GAATGGTCAT GGTAATGACA ATAACTGAGC AAAGTAATTT 2580
AATTTTTTAA GGTGTTACAG TTCTCTAGAG AAGCAGAATC AGTAGGATAC TGGGGATAGT 2640
GGGGAGGGGA GAGAGATTTA TTCTAAGCAG TTAGCTCAAG AGTATAGAAG CTAGCGACTC 2700
CAAAATCTTC AGGGTAAGCC AGCAGGCTAG AATCAGGAAA GAGTTGATGC TTTGAGTGTG 2760
AAGGCCGTCT GCTGACAAAA TTCCTCTTCT TGGGCGAGGT CAGTATTTTT CTATGAAGGC 2820
CTTCAACTGA TTAGATGAGG ACCATCCACA TGATTAGATG GTCCTCATCT AAGTAGACTT 2880
AATAAGTCTA CTAATTTAAA TGTTAACATT TAAATGTTAA GCTCATTTTA AAAAACACCT 2940
TCACGGAAAC ATCTAAAATA ATGTTTGGCC AAATATCTGG GTACCATGCC TATCGAATTT 3000
GACACATACA ATTAACCATC ACAGAATGTA TTAAAATCTT TAAATTACTT TTCTGTGGGG 3060
TGCTTTGTTG GTGAAGCAGG 3080